Publication Cover
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 8, 2000 - Issue 16: Reproductive rights, advocacy and changing the law
150
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Strategies for prevention of mother-to-child transmission of HIV

Pages 144-155 | Published online: 01 Nov 2000

References

  • International AIDS Society position paper. Prevention of mother to child transmission of HIV. Global Strategies for Prevention of HIV Transmission from Mothers to Infants COnference. September 1999, Montreal, Canada 1999. (unpublished) Distributed at the.
  • UNAIDS/WHO. AIDS epidemic update. December 1999
  • C.F. Gilks, E. Katabira, K.M. De Cock. The challenge of providing effective care for HIV/AIDS in Africa. AIDS. 11: 1997; S99–S106. (suppl B).
  • K.A. Stanecki, P.O. Way. The demographic impacts of HIV/AIDS: Perspectives from the world population profile: 1996. March 1997; International Programme Center, Population Division, U.S. Bureau of the Census: Washington D.C. 20233.
  • The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immuno-deficiency virus type 1: a meta-analysis of 15 prospective cohort studies. New England Journal of Medicine. 340: 1999; 977–987.
  • European Collabarative Study. The natural history of vertically acquired HIV infection. Journal of Perinatal Medicine. 19(Suppl 1): 1991; 257–262.
  • P. Datta, J.E. Embree, J.K. Kreiss. Mother to child transmission of human immuno-deficiency virus type-1: Report from the Nairobi Study. Journal Infectious Diseases. 170: 1994; 1134–1140.
  • M. Bulterys, A. Chao, A. Dushimimana. Multiple sexual partners and mother to child transmission of HIV-1. AIDS. 7: 1993; 1639–1645.
  • L.M. Mofenson, J.A. McIntyre. Advances and research directions in the prevention of mother to child HIV-1 transmission. Lancet. 355: 2000; 2237–2244.
  • Connor E M, Sperling RS, Gelber R. et al. Reduction of maternal infant transmission of human immuno-deficiency virus type 1 with zidovudine treatment Paediatric AIDS Clinical trials Group Protocol 076 Study Group.
  • L.M. Mofenson, J.S. Lambert, R. Stiehm. Risk factors for transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New England Journal of Medicine. 341(6): 1999; 385–393.
  • N. Shaffer, R. Chuachoowong, P.A. Mock. Short course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 353: 1999; 773–780.
  • M. Lallemant, G. Jourdain, S. Le Coeur. A trial of shortened zidovudine regimens to prevent mother to child transmission of human immuno-deficiency virus type 1. New England Journal of Medicine. 343(14): 2000; 982–991.
  • S. Wiktor, E. Ekpini, J.M. Karon. Short course oral zidovudine for prevention of mother to child transmission of HIV-1 in Abidjan, Côte d’Ivoire: a randomised trial. Lancet. 353: 1999; 781–785.
  • F. Dabis, P. Msellati, N. Meda. For the DITRAME study group. 6 month efficacy, tolerance, and acceptability of a short course regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double blind placebo controlled multi-centre trial. Lancet. 353: 1999; 786–792.
  • J. Saba Current status of the Petra study Second Conference on Global Strategies for the Prevention of HIV from Mothers to Infants. Montreal, Canada September 1–6,1999,
  • L.A. Guay, P. Musoke, T. Flemming. Intrapartum and neonatal single dose nevirapine compared with zidovudine for the prevention of mother to child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354(9): 1999; 795–802.
  • New initiative to reduce HIV transmission from mother to children low income countries. 29th June 1998; UNAIDS: Geneva. (Press release).
  • M. Berer. Reducing perinatal transmission in developing countries through antenatal and delivery care, and breastfeeding: supporting infant survival by supporting maternal survival. Bulletin of World Health Organization. 77(11): 1999; 871–877.
  • S. Acharya. How effective is antenatal care to promote maternal and neonatal health?. International Journal of Gynecology and Obstetrics. 50(supp. 2): 1995; S35–S42.
  • M. Miroschink, T. Fenton, P. Gagnier. Pharmacokinetics of nevirapine in human immunodeficiency virus type-1 infected pregnant women and their neonates. Journal of Infectious Diseases. 178: 1998; 368–374.
  • P. Musoke, L.A. Guay, D. Bagenda. A phase I/II trial of the safety and pharmacokinetics of nevirapine in HIVA infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 13: 1999; 479–486.
  • E. Marseille, J.G. Kahn, J. Saba. Cost effectiveness of antiretroviral drug therapy to reduce mother to child transmission in sub-Saharan Africa. AIDS. 12: 1998; 939–948.
  • S.Z. Wiktor, V. Leroy, E.R. Ekpini 24-month efficacy of shortcourse maternal zidovudine for the prevention of mother-tochild HIV-1 transmission in a breast feeding population: A pooled analysis of two randomized clinical trials in West Africa Abstract TuOrB354. 13th International AIDS Conference. Durban, South Africa 9–14 July 2000,
  • M. Owor, M. Deseyve, C. Duefield The one year safety and efficacy data of the HIVNET 012 trial Abstract LbOr1. 13th International AIDS Conference. Durban, South Africa 9–14 July 2000,
  • G. Gray. PETRA Trial Management Committee The Petra study: early and late efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1 Abstract LbOr5. 13th International AIDS Conference. Durban, South Africa 9–14 July 2000, for the.
  • L.M. Mofenson, M.G. Fowler. Interruption of materno-fetal transmission. AIDS. 13: 1999; 5205–5214. (suppl A).
  • The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. New England Journal of Medicine. 340: 1999; 977–987.
  • The European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in prevention of vertical transmission: a randomised clinical trial. Lancet. 353: 1999; 1035–1039.
  • M. Bulterys, A. Chao, A. Dushimimana. Fatal complications after caesarean section in 156 HIV positive women. AIDS. 10: 1996; 923–924.
  • D.T. Dunn, M.L. Newell, A.E. Ades. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 340(8819): 1992; 585–588.
  • R. Nduati, G. John, D. MboriNgacha. Effect of breastfeeding and formula feeding on transmission of HIV1 A randomised clinical trial. Journal of American Medical Association. 283(9): 2000; 116–774.
  • B.H. Tess, L.C. Rodrigues, M.L. Newell. Infant feeding and risk of mother to child transmission of HIV-1 in Sao Paulo state, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV. Journal ofAcquired Immune Deficiency Syndrome and Human Retrovirology. 19(2): 1998; 189–194.
  • A. Coutsoudis, K. Pillay, E. Spooner. South African Vitamin A Study Group Influence of infant feeding patterns on early mother to child transmission of HIVA in Durban, South Africa: a prospective cohort study. Lancet. 354: 1999; 471–476.
  • World Health Organisation. Consensus statement from WHO/UNICEF Consultation on HIV transmission and breastfeeding. 1992; Global Programme on AIDS: Geneva. (WHO/GPA/INF/92.1).
  • WHO/UNAIDS/UNICEF. HIV and infant feeding: Implementation guidelines. 1998. WHO/FRH/CHD/98.4, UNAIDS/98.6, UNICEF/PD/NUT(J) 98-4 ed.
  • Technical report of the UNICEF-UNAIDS-WHO. Technical consultation on HIV and infant feeding, Geneva.
  • M.C. Latham, E.A. Preble. Appropriate feeding methods for infants of HIV infected mothers in sub-Saharan Africa. British Medical Journal. 320: 2000; 1656–1660.
  • M.P. Cartoux, N. Meda, P. Van de Perre. Acceptability of voluntary testing and counselling by pregnant women in developing countries: an international survey. AIDS. 12: 1997; 2489–2493.
  • S.L. Mckenna, G.K. Muyinda, D. Roth. Rapid HIV testing and counselling for the voluntary testing centers in Africa. AIDS. 11(suppl 1): 1997; S103–S110.
  • G.J. Bhat, S. Mckenna, H. Terenuma. Same day voluntary testing and counselling improves overall acceptability among prenatal women in Zambia. 12th World AIDS Conference. June–July 1998. Abstract 649, Geneva.
  • R.J. Biggar, P.G. Miotti, Taha E.T.T.. Perinatal intervention trial in Africa; effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 347: 1996; 1647–1650.
  • E.T.T. Taha, R.J. Biggar, R.L. Broadhead. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: a clinical trial. British Medical Journal. 315: 1996; 216–219.
  • R.D. Semba, P.G. Miotti, J.D. Chiphangwi. Maternal vitamin A deficiency and mother to child transmission of HIV-1. Lancet. 343(8913): 1994; 1593–1597.
  • T.O. Scholl, M.L. Hedger, A. Bendish. Use of vitamin A supplements: influence on pregnancy outcome. American Journal of Epidemiology. 146: 1997; 134–141.
  • R.L. Goldenberg, D.J. Rouse. Prevention of premature birth. New England Journal of Medicine. 338: 1998; 313–320.
  • N. Meda, B. Dao, A. Ouangre. For the Ditrame Study Group (ANRS 049 Clinical Trial). HIV, maternal anemia and perinatal intervention using zidovudine. International Journal of Gynecology and Obstetrics. 61: 1997; 65–66.
  • A. Coutsoudis, K. Pillay, E. Spooner. Randomised trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother to child HIV-1 transmission in Durban, South Africa. South Africa Vitamin A Study Group. AIDS. 13(12): 1999; 1517–1524.
  • W.W. Fawzi, G.I. Msamanga, D. Spiegelman. For the Tanzania Vitamin and HIV I infection Trial Team. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIVA infected women in Tanzania. Lancet. 351: 1997; 1477–1482.
  • B.P. Bloland, J.J. Wirima, R.W. Steketee. JG Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS. 9(7): 1995; 721–726.
  • R.W. Steketee, J.J. Wirima, B.P. Bloland. Impairment of a pregnant woman’s acquired ability to limit plasmodium falciparum by infection with human immunodeficiency virus type-1. American Journal of Tropical Medicine and Hygiene. 550: 1996; 42–49.
  • F.H. Verhoef, B.J. Brabin, C.A. Hart. Increased prevalence of malaria in HIV infected pregnant women and implications for malaria control. Tropical Medicine and International Health. 4(1): 1999; 5–12.
  • M.E. Parise, J.G. Ayisi, B.L. Nahlen. Efficacy of sulfadoxinepyrimethamine for prevention of placental malaria in an area of Kenya with high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene. 59(5)): 1998; 813–822.
  • E. Wood, P. Braitstein, J.S.G. Montaner. Extent to which low level use of anti-retroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet. 355: 2000; 2095–2100.
  • R. French, P. Brocklehurst. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. British Journal of Obstetrics and Gynaecology. 105: 1998; 827–835.
  • A. Kamali, J.A. Seeley, A.J. Nunn. The orphan problem: experience of a sub-Saharan rural population in the AIDS epidemic. AIDS Care. 8(5): 1996; 509–515.
  • S. Blanche, M. Tardieu, P. Rustin. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 354: 1999; 1084–1089.
  • M.E. Smith. US Nucleoside Safety Review Working Group Ongoing nucleoside safety review of HIV exposed children in US studies 2nd Conference on HIV on Global strategies for the Prevention of Transmission of HIV from Mothers to Infants. Montreal September 1999. Abstract 096.
  • P. Piot, A. Coll-Seck. Preventing mother to child transmission of HIV in Africa. Bulletin of World Health Organization. 77(11): 1999; 869–970.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.